Result of AGM

19th Nov 2008 12:41

19 NOVEMBER 2008

 

HENDERSON MORLEY PLC

(AIM: HML)

 

RESULT OF AGM 

 

 

The Board of Henderson Morley plc ("Henderson Morley" or "the Company"), the AIM quoted biotechnology company, announces that at the Company's Annual General Meeting held earlier today, all the resolutions were duly passed.

 

---ENDS---

 

 

ENQUIRIES:

 

HENDERSON MORLEY PLC 0121 442 4600

Andrew Knight, Chairman

 

BISHOPSGATE COMMUNICATIONS LTD 0207 562 3350

Maxine Barnes

Nick Rome

 

BREWIN DOLPHIN INVESTMENT BANKING 0113 241 0126

Neil Baldwin

 

HYBRIDAN LLP 0203 159 5085

Claire Noyce/Stephen Austin

 

Further information on Henderson Morley plc can be accessed through the Company's website at www.henderson-morley.com 

 

 

Notes to Editors:

 

Henderson Morley was founded in 1996 with the objective of developing its anti viral application (Ionic Contra Viral Therapy (ICVT). ICVT is the Lead Platform and has been developed in-house and HML wholly owns the patent IPR. 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ENDRAGFFSFEUSASELF

---

Related Shares:

HML.L